The presence of the JAK-2 mutation suggests polycythemia vera, essential thrombocytosis, or myelofibrosis, while a positive BCR-ABL mutation is diagnostic for chronic myeloid leukemia. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.